Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Assets: 2022-2024

Historic Assets for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Dec 2024 value amounting to $576.8 million.

  • Centessa Pharmaceuticals' Assets fell 26.47% to $448.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $448.3 million, marking a year-over-year decrease of 26.47%. This contributed to the annual value of $576.8 million for FY2024, which is 60.11% up from last year.
  • According to the latest figures from FY2024, Centessa Pharmaceuticals' Assets is $576.8 million, which was up 60.11% from $360.2 million recorded in FY2023.
  • In the past 5 years, Centessa Pharmaceuticals' Assets ranged from a high of $576.8 million in FY2024 and a low of $360.2 million during FY2023.
  • Over the past 3 years, Centessa Pharmaceuticals' median Assets value was $444.3 million (recorded in 2022), while the average stood at $460.5 million.
  • Its Assets has fluctuated over the past 5 years, first fell by 18.92% in 2023, then skyrocketed by 60.11% in 2024.
  • Centessa Pharmaceuticals' Assets (Yearly) stood at $444.3 million in 2022, then fell by 18.92% to $360.2 million in 2023, then surged by 60.11% to $576.8 million in 2024.